Core Insights - The company, Yejun Medical Group Holdings Limited, received the "Annual Outstanding Overseas Award" at the 2025 Golden Award for Excellence, highlighting its international influence and achievements in cross-border cooperation [1][3]. Group 1 - Yejun Medical has been dedicated to developing innovative interventional treatment solutions for over 20 years, establishing a global network with R&D, manufacturing, and logistics bases in China, Japan, Germany, and the Netherlands [1]. - The company has a strong sales engine consisting of 14 direct sales teams and over 300 distributors across various countries, enabling it to deliver innovative medical devices to over 70 countries and regions [1]. - The award recognizes companies that efficiently allocate global resources and integrate deeply into international industrial chains, enhancing the brand value, pricing power, and industry voice of Chinese enterprises in the global market [1].

Core Insights - The company reported a revenue of $83.6 million for the six months ending June 30, 2025, representing a 5.9% increase year-on-year [1] - Core operating profit increased by 11.4% to $15.1 million, while profit attributable to shareholders rose by 5.1% to $19.8 million [1] - The company declared a special cash dividend of HKD 0.15 per ordinary share, celebrating its 25th anniversary, alongside a final dividend of HKD 0.10 per share paid on June 16, 2025, totaling HKD 0.25 per share for 2025 [1] Financial Performance - Revenue growth was driven by strong performance in the U.S. market and contributions from emerging markets in the Asia-Pacific, Europe, the Middle East, and Africa [1][2] - The company maintained a robust financial position with cash and bank balances reaching $237.1 million as of June 30, 2025 [1] Strategic Outlook - The CEO emphasized the company's commitment to innovation and global commercialization, which has established a strong reputation and resilience through various economic cycles [2] - The company aims to enhance brand value and competitive advantage through direct sales coverage, excellent sales support, investment in innovation, and a comprehensive range of PCI and PTA products [2]